Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaMarco L. Davila, Renier J. Brentjens, James Hosey et al.|Science Translational Medicine|2014Cited by 2.5k
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCatherine C. Coombs, Michael F. Berger, David M. Hyman et al.|Cell stem cell|2017Cited by 851
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung CancerChristian Rolfo, David R. Gandara, Philip C. Mack et al.|Journal of Thoracic Oncology|2021Cited by 642
Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer: Distinct Natural History of Patients with Tumors Harboring the T790M MutationGeoffrey R. Oxnard, Vincent A. Miller, Maria E. Arcila et al.|Clinical Cancer Research|2010Cited by 624
Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based AssayMaria E. Arcila, Marc Ladanyi, Geoffrey R. Oxnard et al.|Clinical Cancer Research|2011Cited by 574